期刊文献+

人呼吸道合胞病毒F1蛋白的原核表达及纯化

Prokaryotic Expression and Purification of F1 Protein of Human Respiratory Syncytial Virus
原文传递
导出
摘要 目的克隆A型人呼吸道合胞病毒(Human respiratory syncytial virus,HRSV)兰州分离株F1基因,并进行原核表达和纯化。方法采用RT-PCR方法克隆RSV F1 ORF序列,克隆至pET-42b(+)表达载体,构建重组原核表达质粒pET-42b-F1,转化大肠杆菌Rossata(DE3),IPTG诱导表达,表达产物经SDS-PAGE和Western blot鉴定后,用GST亲和层析树脂进行纯化。结果重组原核表达质粒经双酶切及测序证明构建正确;表达的融合蛋白相对分子质量约77 000,表达量约占菌体总蛋白的20%,以包涵体和可溶性两种形式存在;该蛋白可与鼠抗人RSV单抗发生特异性反应,纯化后纯度约为50%。结论已原核表达并纯化了HRSV F1蛋白,为其血清抗体的制备及免疫原性研究奠定了基础。 Objective To clone the F1 gene of Lanzhou isolate of human respiratory syncytial virus(HRSV) type A,express in prokaryotic cells and purify the expressed product.Methods The ORF sequence of HRSV F1 was amplified by RT-PCR and cloned into expression vector pET-42b(+).The constructed recombinant plasmid pET-42b-F1 was transformed to E.coli Rossata(DE3) for expression under induction of IPTG.The expressed product was identified by SDS-PAGE and Western blot,then purified by affinity chromatography with GST Binding Resin.Results Restriction analysis and sequencing proved that recombinant plasmid pET-42b-F1 was constructed correctly.The expressed fusion protein,with a relative molecular mass of about 77 000,contained about 20% of total somatic protein and existed in both soluble and inclusion body forms.The protein showed specific reaction with mouse anti-human RSV McAb,and reached a purity of about 50% after purification.Conclusion HRSV F1 protein was expressed in prokaryotic cells and purified,which laid a foundation of preparation and study on immunogenicity of serum antibody.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第8期873-876,共4页 Chinese Journal of Biologicals
关键词 呼吸道合胞病毒 F1基因 克隆 分子 原核细胞 基因表达 纯化 Respiratory syncytial virus human F1 gene Cloning molecular Prokaryotic cells Gene expression Purification
  • 相关文献

参考文献11

  • 1Day ND, Branigan PJ, Liu C, et ol. Contribution of cysteine residues in the extracellular domain of the F protein of human respiratory syncytial virus to its function [J]. Virol J, 2006, 3 (1): 34-44.
  • 2Subbarayan P, Qin H, Pillai S, et al. Expression and characterization of a multivalent human respiratory syncytial virus protein [J]. Mol Biol(mosk), 2010, 44 (3): 477-487.
  • 3Vig K, Boyoglu S, Rangari V, et al. Respiratory syncytial virus interactions with nanoparticles using transmission electron microscopy [J]. Biophys J, 2010, 98 (3): 655a.
  • 4Hacking D, Hull J. Respiratory syncytial virus-viral biology and the host response [J]. J Infect, 2002, 45 (1) : 18-24.
  • 5范行良,周铁群.呼吸道合胞病毒F蛋白研究进展[J].微生物学免疫学进展,2004,32(4):73-76. 被引量:9
  • 6Yunus AS, Jackson TP, Crisafi K, et al. Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation [J]. Virology, 2010, 396 (2) : 226-237.
  • 7Areuri HA, Apponi LH, Valentini SR, et al. Expression and purification of human respiratory syncytial virus recombinant fusion protein [J]. Protein Expr Purif, 2008, 62 (2): 146-152.
  • 8Ternette N, Tippler B, Uberla K, et al. Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus [J]. Vaccine, 2007, 25 (4): 7271-7279.
  • 9Wu H, Pfarr DS, Tang Y, et al. Ultra-potent antibodies against respiratory syncytial virus : effects of binding kinetics and binding valence on viral neutralization [J]. J Mol Biol, 2005, 350 (1): 126-144.
  • 10Zhan X, Hurwitz JL, Krishnamurthy S, et ol. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV tubtype A and B[J]. Vaccine, 2007, 25 (52) : 8782- 8793.

二级参考文献16

  • 1Johnson PR, Collins PL. The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness[J].J Gen Virol 1988,69 ( Pt 10): 2623-2628.
  • 2Lopez JA, Andreu D, Carreno C, et al. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein[J].J Gen Virol 1993, 74 ( Pt 12):2567-2577.
  • 3Jiang S, Borthwick NJ, Morrison P,et al. Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus[J]. J Gen Virol 2002,83(Pt 2):429-438.
  • 4Gonzalez RL, Arguello RMB, Garcia BB,et al. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion[J].Proc Natl Acad Sci USA 2001,98(17):9859-9864.
  • 5Sakurai H,Williamson RA, Crowe JE ,et al. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines[J]. J Virol 1999,73(4): 2956-2962.
  • 6Argüello MBR, Luis GR, Calder LJ ,et al. Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment[J].Virology 2002,298(2):317-
  • 7Chang J, Srikiatkhachorn A, Braciale TJ,et al. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection[J]. J Immunol 2001,167(8):4254-4260.
  • 8Levely ME, Bannow CA, Smith CW,et al. Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes[J]. J Virol 1991,65(7):3789-3796.
  • 9Zimmer G, Trotz I, Herrler G. N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus[J].J Virol 2001,75(10):4744-4751.
  • 10Collins PL, Mottet G. Post-translational processing and oligomerization of the fusion glycopro tein of human respiratory syncytial virus[J].J Gen Virol 1991,72 ( Pt 12): 3095-3101.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部